The requests kept coming. More Second Opinion. More sharp takes on brand strategy for MedTech leaders. More video!
So we gave our popular videos a dedicated new channel.
The F&N Med YouTube channel is live — with case studies, the full Second Opinion series, MedTech brand stats, and our new short-form series Second Opinion Sprints for leaders who are building fast and can’t afford to ignore brand.
An Act of Compassionate Innovation. One of the greatest limitations for patients living with lymphedema is the visual, mental,...
A New Answer to Back Pain. A $1B Exit. Lower back pain. One of the most common and most misunderstood...
Build to the stage. Scale the story. Win big. Part VI in our “When to Invest In Brand” for growth-stage...
The Practical Reality: Brand Investment Is About Intelligent Sequencing. Part V in our “When to Invest In Brand” for growth-stage...
Introducing Second Opinion Sprints. MedTech leader that needs a take on brand, but is short on time? Introducing Second Opinion...
Why MedTech Companies Can’t Wait Past Series B To Build A Strategic Brand. Part IV in our “When to Invest...
The Series A–B Inflection: When Brand Becomes MedTech Infrastructure Part II in our “When to Invest In Brand” for growth-stage...
Picking a Fight with Calcium. Scoring a $1B TKO. Cardiovascular Systems, Inc. had a bold product, an aggressive culture,...
Part 2: Why Brand Strategy Needs to Start Earlier Than Most Founders Think (Late Seed to Early A) In early-stage...
When to Invest in Brand (And Why Timing Is Everything in MedTech) Part I: The quiet question shaping MedTech...